Explore the latest books of this year!
Bookbot
You'll get the exact copy in the photo

A Lippincott Williams & Wilkins Handbook: Handbook of Cancer Chemotherapy - Seventh Edition

Parameters

  • 817 pages
  • 29 hours of reading

More about the book

The Seventh Edition of this pocket reference is a practical, disease-focused guide to the best current medical practice in cancer chemotherapy. In easy-to-follow outline format, the book provides complete coverage of the principles of rational chemotherapy, the chemotherapeutic and biotherapeutic agents available, the treatment of specific cancers, and selected aspects of supportive care. Emphasis is on the indications, dosage/schedule, potential toxicities, and safe administration of the drugs and their use in treating specific malignancies. This edition describes seventeen new chemotherapeutic agents, with particular attention to molecular targeted agents. Updated chapters on individual cancers and supportive care provide state-of-the-art treatment recommendations.

Book purchase

A Lippincott Williams & Wilkins Handbook: Handbook of Cancer Chemotherapy - Seventh Edition, Roland T. Skeel

Language
Released
2007
Binding
(Paperback),
Book condition
Good
Price
€9.99

Payment methods

No one has rated yet.

Title
A Lippincott Williams & Wilkins Handbook: Handbook of Cancer Chemotherapy - Seventh Edition
Language
English
Released
2007
Format
Paperback
Pages
817
ISBN10
0781765315
ISBN13
9780781765312
Series
Description
The Seventh Edition of this pocket reference is a practical, disease-focused guide to the best current medical practice in cancer chemotherapy. In easy-to-follow outline format, the book provides complete coverage of the principles of rational chemotherapy, the chemotherapeutic and biotherapeutic agents available, the treatment of specific cancers, and selected aspects of supportive care. Emphasis is on the indications, dosage/schedule, potential toxicities, and safe administration of the drugs and their use in treating specific malignancies. This edition describes seventeen new chemotherapeutic agents, with particular attention to molecular targeted agents. Updated chapters on individual cancers and supportive care provide state-of-the-art treatment recommendations.